Furthermore, significant liver fibrosis was detected in 69.6% and 79.2% of patients with aged < 30 years and aged ≥ 30 years (p = 0.026), and in 53.7%, 50.1% and 86.7% of patients with ALT < 1 × ULN, 1–2 × ULN, and ≥ 2 × ULN, respectively (Fig. 2B). This evidence concerns the gene GPT and Hepatic fibrosis.